Nutrition and pancreatic cancer

Anticancer Research

Volumn 34, Issue 1, 2014, Pages 9-21

  Pericleous, Marinos ^a   Rossi, Roberta Elisa ^a,b   Mandair, Dalvinder ^a   Whyand, Tara ^a   Caplin, Martyn Evan ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Alcohol; Carcinogenesis; Diet; Dietary factors; Epidemiology; Lifestyle; Nutrition; Pancreatic cancer; Review; Smoking

Indexed keywords

BETA CAROTENE; CALCIUM; CURCUMIN; DIOSMIN; ESTROGEN; FOLIC ACID; HESPERIDIN; ISOFLAVONE DERIVATIVE; LIMONIN; MONOUNSATURATED FATTY ACID; NOMILIN; OMEGA 3 FATTY ACID; POLYPHENOL DERIVATIVE; RUTOSIDE; SATURATED FATTY ACID; SUGAR; UNSATURATED FATTY ACID; VITAMIN D; XANTHOHUMOL; XANTHOPHYLL; ALCOHOL;

ALCOHOL CONSUMPTION; BODY MASS; CANCER RISK; CARCINOGENESIS; CITRUS FRUIT; COFFEE; FAT INTAKE; FISH; FRUIT; GRAIN; HIGH TEMPERATURE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; LIFESTYLE; MENSTRUATION; META ANALYSIS (TOPIC); NUTRITION; OBESITY; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHYSICAL ACTIVITY; POULTRY; RED MEAT; REVIEW; SMOKING; SYSTEMATIC REVIEW; TEA; VEGETABLE; VITAMIN SUPPLEMENTATION; ANIMAL; DIET; DIETARY FACTORS; EPIDEMIOLOGY; FEEDING BEHAVIOR; FEMALE; MALE; NUTRITIONAL STATUS; PANCREAS TUMOR;

ALCOHOL; CARCINOGENESIS; DIET; DIETARY FACTORS; EPIDEMIOLOGY; LIFESTYLE; NUTRITION; PANCREATIC CANCER; REVIEW; SMOKING;

ANIMALS; DIET; FEMALE; FOOD HABITS; HUMANS; MALE; NUTRITIONAL STATUS; PANCREATIC NEOPLASMS;

EID: 84897025634     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (161)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
2. Boyle P, Hsieh CC, Maisonneuve P, La Vecchia C, Macfarlane GJ, Walker AM and Trichopoulos D: Epidemiology of pancreas cancer (1988). Int J Pancreatol 5: 327-346, 1989.
3. Klapman J and Malafa MP: Early detection of pancreatic cancer: Why, who, and how to screen. Cancer Control 15: 280-287, 2008.
4. Freitas D, Fernandes Gdos S, Hoff PM and Cunha JE: Medical management of pancreatic adenocarcinoma. Pancreatology 9: 223-232, 2009.
5. Ghadirian P, Liu G, Gallinger S, Schmocker B, Paradis AJ, Lal G, Brunet JS, Foulkes WD and Narod SA: Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas. Int J Cancer 97: 807-810, 2002.
6. Ghadirian P, Lynch HT and Krewski D: Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev 27: 87-93, 2003.
7. Ghadirian P, Simard A and Baillargeon J: Tobacco, alcohol, and coffee and cancer of the pancreas. A population-based, case-control study in Quebec, Canada. Cancer 67: 2664-2670, 1991.
8. Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L and Li D: Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 102: 2696-2707, 2007.
9. Chan JM, Wang F and Holly EA: Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Cancer Epidemiol Biomarkers Prev 14: 2093-2097, 2005.
10. Ghadirian P and Nkondjock A: Consumption of food groups and the risk of pancreatic cancer: a case-control study. J Gastrointest Cancer 41: 121-129, 2010.
11. Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, Bamlet WR, de Andrade M, Oberg AL, Hammer TJ, Rabe KG, Anderson KE, Olson JE, Sinha R and Petersen GM: Fruit and vegetable consumption is inversely associated with having pancreatic cancer. Cancer Causes Control 22: 1613-1625.
12. Buer CS, Imin N and Djordjevic MA: Flavonoids: new roles for old molecules. J Integr Plant Biol 52: 98-111, 2010.
13. Patil JR, Murthy KNC, Jayaprakasha GK, Chetti MB and Patil BS: Bioactive Compounds from Mexican Lime (Citrus aurantifolia) Juice Induce Apoptosis in Human Pancreatic Cells. J Agric Food Chem 57: 10933-10942, 2009.
14. Marti N, Mena P, Canovas JA, Micol V and Saura D: Vitamin C and the Role of Citrus Juices as Functional Food. Natural Product Communications 4: 677-700, 2009.
15. Patil JR, Jayaprakasha GK, Murthy KNC, Chetti MB and Patil BS: Characterization of Citrus aurantifolia bioactive compounds and their inhibition of human pancreatic cancer cells through apoptosis. Microchemical Journal 94: 108-117, 2010.
16. Tanaka T, Kohno H, Tsukio Y, Honjo S, Tanino M, Miyake M and Wada K: Citrus limonoids obacunone and limonin inhibit azoxymethane-induced colon carcinogenesis in rats. Biofactors 13: 213-218, 2000.
17. Tanaka T, Ota T, Miyake M and Wada K: Citrus limonoids obakunone and limonin inhibit the development of a precursor lesion aberrant crypt foci for colon cancer in rats. Abstracts of Papers of the American Chemical Society 217: U40-U41, 1999.
18. Lin Y, Kikuchi S, Tamakoshi A, Yagyu K, Obata Y, Inaba Y, Kurosawa M, Kawamura T, Motohashi Y and Ishibashi T: Dietary habits and pancreatic cancer risk in a cohort of middleaged and elderly Japanese. Nutr Cancer 56: 40-49, 2006.
19. Larsson SC, Hakansson N, Naslund I, Bergkvist L and Wolk A: Fruit and vegetable consumption in relation to pancreatic cancer risk: A prospective study. Cancer Epidemiol Biomarkers Prev 15: 301-305, 2006.
20. Inoue-Choi M, Flood A, Robien K and Anderson K: Nutrients, food groups, dietary patterns, and risk of pancreatic cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 20: 711-714, 2011.
21. Nothlings U, Wilkens LR, Murphy SP, Hankin JH, Henderson BE and Kolonel LN: Vegetable intake and pancreatic cancer risk: The multiethnic cohort study. Am J Epidemiol 165: 138-147, 2007.
22. Vrieling A, Verhage BA, van Duijnhoven FJ, Jenab M, Overvad K, Tjonneland A, Olsen A, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Rohrmann S, Boeing H, Nothlings U, Trichopoulou A, John T, Dimosthenes Z, Palli D, Sieri S, Mattiello A, Tumino R, Vineis P, van Gils CH, Peeters PH, Engeset D, Lund E, Rodriguez Suarez L, Jakszyn P, Larranaga N, Sanchez MJ, Chirlaque MD, Ardanaz E, Manjer J, Lindkvist B, Hallmans G, Ye W, Bingham S, Khaw KT, Roddam A, Key T, Boffetta P, Duell EJ, Michaud DS, Riboli E and Bueno-de-Mesquita HB: Fruit and vegetable consumption and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 124: 1926-1934, 2009.
23. Chan JM, Wang F and Holly EA: Whole grains and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area, California. Am J Epidemiol 166: 1174-1185, 2007.
24. Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, Bamlet WR, de Andrade M, Oberg AL, Hammer TJ, Rabe KG, Anderson KE, Olson JE, Sinha R and Petersen GM: Fruit and vegetable consumption is inversely associated with having pancreatic cancer. Cancer Causes Control 22: 1613-1625, 2011.
25. Jacobs DR Jr., Marquart L, Slavin J and Kushi LH: Wholegrain intake and cancer: an expanded review and meta-analysis. Nutr Cancer 30: 85-96, 1998.
26. Larsson SC and Wolk A: Red and processed meat consumption and risk of pancreatic cancer: Meta-analysis of prospective studies. Br J Cancer 106: 603-607.
27. Stolzenberg-Solomon RZ, Cross AJ, Silverman DT, Schairer C, Thompson FE, Kipnis V, Subar AF, Hollenbeck A, Schatzkin A and Sinha R: Meat and meat-mutagen intake and pancreatic cancer risk in the NIH-AARP cohort. Cancer Epidemiol Biomarkers Prev 16: 2664-2675, 2007.
28. Inoue-Choi M, Flood A, Robien K and Anderson K: Nutrients, food groups, dietary patterns and risk of pancreatic cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 20: 711-714.
29. Rohrmann S, Linseisen J, Nothlings U, Overvad K, Egeberg R, Tjonneland A, Boutron-Ruault MC, Clavel-Chapelon F, Cottet V, Pala V, Tumino R, Palli D, Panico S, Vineis P, Boeing H, Pischon T, Grote V, Teucher B, Khaw KT, Wareham NJ, Crowe FL, Goufa I, Orfanos P, Trichopoulou A, Jeurnink SM, Siersema PD, Peeters PH, Brustad M, Engeset D, Skeie G, Duell EJ, Amiano P, Barricarte A, Molina-Montes E, Rodriguez L, Tormo MJ, Sund M, Ye W, Lindkvist B, Johansen D, Ferrari P, Jenab M, Slimani N, Ward H, Riboli E, Norat T and Bueno-de-Mesquita HB: Meat and fish consumption and risk of pancreatic cancer: results from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 132: 617-624, 2013.
30. Michaud DS, Giovannucci E, Willett WC, Colditz GA and Fuchs CS: Dietary meat, dairy products, fat, and cholesterol and pancreatic cancer risk in a prospective study. Am J Epidemiol 157: 1115-1125, 2003.
31. Nothlings U, Wilkens LR, Murphy SP, Hankin JH, Henderson BE and Kolonel LN: Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J Natl Cancer Inst 97: 1458-1465, 2005.
32. Larsson SC, Hakanson N, Permert J and Wolk A: Meat, fish, poultry and egg consumption in relation to risk of pancreatic cancer: a prospective study. Int J Cancer 118: 2866-2870, 2006.
33. Anderson KE, Sinha R, Kulldorff M, Gross M, Lang NP, Barber C, Harnack L, DiMagno E, Bliss R and Kadlubar FF: Meat intake and cooking techniques: associations with pancreatic cancer. Mutat Res 506-507: 225-231, 2002.
34. Li D, Day RS, Bondy ML, Sinha R, Nguyen NT, Evans DB, Abbruzzese JL and Hassan MM: Dietary mutagen exposure and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 16: 655-661, 2007.
35. Zheng W, McLaughlin JK, Gridley G, Bjelke E, Schuman LM, Silverman DT, Wacholder S, Co-Chien HT, Blot WJ and Fraumeni JF Jr.: A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control 4: 477-482, 1993.
36. Douglas BR, Woutersen RA, Jansen JB, de Jong AJ, Rovati LC and Lamers CB: Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas. Gastroenterology 96: 462-469, 1989.
37. Qin B, Xun P and He K: Fish or long-chain (n-3) PUFA intake is not associated with pancreatic cancer risk in a meta-analysis and systematic review. J Nutr 142: 1067-1073, 2012.
38. Heinen MM, Verhage BA, Goldbohm RA and van den Brandt PA: Meat and fat intake and pancreatic cancer risk in the Netherlands Cohort Study. Int J Cancer 125: 1118-1126, 2009.
39. Rohrmann S, Linseisen J, Becker N, Norat T, Sinha R, Skeie G, Lund E, Martinez C, Barricarte A, Mattisson I, Berglund G, Welch A, Davey G, Overvad K, Tjonneland A, Clavel-Chapelon F, Kesse E, Lotze G, Klipstein-Grobusch K, Vasilopoulou E, Polychronopoulos E, Pala V, Celentano E, Bueno-De-Mesquita HB, Peeters PH, Riboli E, Slimani N, European Prospective Investigation into C and Nutrition: Cooking of meat and fish in Europe - results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Clin Nutr 56: 1216-1230, 2002.
40. Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nalsen C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gustafsson IB, Storlien LH and Study K: Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 44: 312-319, 2001.
41. He K, Xun P, Brasky TM, Gammon MD, Stevens J and White E: Types of fish consumed and fish preparation methods in relation to pancreatic cancer incidence: the VITAL Cohort Study. Am J Epidemiol 177: 152-160, 2013.
42. Chan JM, Wang F and Holly EA: Pancreatic cancer, animal protein and dietary fat in a population-based study, San Francisco Bay Area, California. Cancer Causes Control 18: 1153-1167, 2007.
43. Nkondjock A, Krewski D, Johnson KC, Ghadirian P and Canadian Cancer Registries Epidemiology Research G: Specific fatty acid intake and the risk of pancreatic cancer in Canada. Br J Cancer 92: 971-977, 2005.
44. Appel MJ, Meijers M, Van Garderen-Hoetmer A, Lamers CB, Rovati LC, Sprij-Mooij D, Jansen JB and Woutersen RA: Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats. British journal of cancer 66: 46-50, 1992.
45. Tucker ON, Dannenberg AJ, Yang EK and Fahey TJ, 3rd: Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines. Carcinogenesis 25: 419-423, 2004.
46. Lopez S, Bermudez B, Pacheco YM, Villar J, Abia R and Muriana FJ: Distinctive postprandial modulation of beta cell function and insulin sensitivity by dietary fats: monounsaturated compared with saturated fatty acids. Am J Clin Nutr 88: 638-644, 2008.
47. Gong Z, Holly EA, Wang F, Chan JM and Bracci PM: Intake of fatty acids and antioxidants and pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Int J Cancer 127: 1893-1904, 2010.
48. Zhang J, Dhakal IB, Gross MD, Lang NP, Kadlubar FF, Harnack LJ and Anderson KE: Physical activity, diet, and pancreatic cancer: A population-based, case-control study in Minnesota. Nutr Cancer 61: 457-465, 2009.
49. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J and Albanes D: Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol 155: 783-792, 2002.
50. Thiebaut AC, Jiao L, Silverman DT, Cross AJ, Thompson FE, Subar AF, Hollenbeck AR, Schatzkin A and Stolzenberg-Solomon RZ: Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study. J Natl Cancer Inst 101: 1001-1011, 2009.
51. Larsson SC, Bergkvist L and Wolk A: Consumption of sugar and sugar-sweetened foods and the risk of pancreatic cancer in a prospective study. Am J Clin Nutr 84: 1171-1176, 2006.
52. Mueller NT, Odegaard A, Anderson K, Yuan JM, Gross M, Koh WP and Pereira MA: Soft drink and juice consumption and risk of pancreatic cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 19: 447-455, 2010.
53. Gallus S, Turati F, Tavani A, Polesel J, Talamini R, Franceschi S and La Vecchia C: Soft drinks, sweetened beverages and risk of pancreatic cancer. Cancer Causes Control 22: 33-39, 2011.
54. Schernhammer ES, Hu FB, Giovannucci E, Michaud DS, Colditz GA, Stampfer MJ and Fuchs CS: Sugar-sweetened soft drink consumption and risk of pancreatic cancer in two prospective cohorts. Cancer Epidemiol Biomarkers Prev 14: 2098-2105, 2005.
55. Genkinger JM, Li R, Spiegelman D, Anderson KE, Albanes D, Bergkvist L, Bernstein L, Black A, van den Brandt PA, English DR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Goldbohm RA, Horn-Ross PL, Jacobs EJ, Koushik A, Mannisto S, Marshall JR, Miller AB, Patel AV, Robien K, Rohan TE, Schairer C, Stolzenberg-Solomon R, Wolk A, Ziegler RG and Smith-Warner SA: Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: A pooled analysis of 14 cohort studies. Cancer Epidemiol Biomarkers Prev 21: 305-318, 2012.
56. Pisani P: Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 114: 63-70, 2008.
57. Rosato V, Tavani A, Bosetti C, Pelucchi C, Talamini R, Polesel J, Serraino D, Negri E and La Vecchia C: Metabolic syndrome and pancreatic cancer risk: A case-control study in Italy and meta-analysis. Metabolism 60: 1372-1378, 2011.
58. Pandey A, Forte V, Abdallah M, Alickaj A, Mahmud S, Asad S and McFarlane SI: Diabetes mellitus and the risk of cancer. Minerva Endocrinol 36: 187-209, 2011.
59. Chiou WK, Hwang JS, Hsu KH and Lin JD: Diabetes mellitus increased mortality rates more in gender-specific than in nongender-specific cancer patients: A retrospective study of 149,491 patients. Exp Diabetes Res 2012: 701643, 2012.
60. Luo J, Chlebowski R, Liu S, McGlynn KA, Parekh N, White DL and Margolis KL: Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. Cancer Causes Control 24: 577-585, 2013.
61. Bodmer M, Becker C, Meier C, Jick SS and Meier CR: Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis. The American journal of gastroenterology 107: 620-626, 2012.
62. Soranna D, Scotti L, Zambon A, Bosetti C, Grassi G, Catapano A, La Vecchia C, Mancia G and Corrao G: Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis. The oncologist 2012.
63. Wolpin BM, Bao Y, Qian ZR, Wu C, Kraft P, Ogino S, Stampfer MJ, Sato K, Ma J, Buring JE, Sesso HD, Lee IM, Gaziano JM, McTiernan A, Phillips LS, Cochrane BB, Pollak MN, Manson JE, Giovannucci EL and Fuchs CS: Hyperglycemia, insulin resistance, impaired pancreatic beta-cell function and risk of pancreatic cancer. J Natl Cancer Inst 105: 1027-1035, 2013.
64. Talamini R, Polesel J, Gallus S, Dal Maso L, Zucchetto A, Negri E, Bosetti C, Lucenteforte E, Boz G, Franceschi S, Serraino D and La Vecchia C: Tobacco smoking, alcohol consumption and pancreatic cancer risk: A case-control study in Italy. European journal of cancer 46: 370-376, 2010.
65. Tramacere I, Scotti L, Jenab M, Bagnardi V, Bellocco R, Rota M, Corrao G, Bravi F, Boffetta P and La Vecchia C: Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. Int J Cancer 126: 1474-1486, 2010.
66. Jiao L, Silverman DT, Schairer C, Thiebaut AC, Hollenbeck AR, Leitzmann MF, Schatzkin A and Stolzenberg-Solomon RZ: Alcohol use and risk of pancreatic cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol 169: 1043-1051, 2009.
67. Genkinger JM, Spiegelman D, Anderson KE, Bergkvist L, Bernstein L, van den Brandt PA, English DR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Hankinson SE, Horn-Ross PL, Leitzmann M, Mannisto S, Marshall JR, McCullough ML, Miller AB, Reding DJ, Robien K, Rohan TE, Schatzkin A, Stevens VL, Stolzenberg-Solomon RZ, Verhage BA, Wolk A, Ziegler RG and Smith-Warner SA: Alcohol intake and pancreatic cancer risk: A pooled analysis of fourteen cohort studies. Cancer Epidemiol Biomarkers Prev 18: 765-776, 2009.
68. Rohrmann S, Linseisen J, Vrieling A, Boffetta P, Stolzenberg-Solomon RZ, Lowenfels AB, Jensen MK, Overvad K, Olsen A, Tjonneland A, Boutron-Ruault MC, Clavel-Chapelon F, Fagherazzi G, Misirli G, Lagiou P, Trichopoulou A, Kaaks R, Bergmann MM, Boeing H, Bingham S, Khaw KT, Allen N, Roddam A, Palli D, Pala V, Panico S, Tumino R, Vineis P, Peeters PH, Hjartaker A, Lund E, Redondo Cornejo ML, Agudo A, Arriola L, Sanchez MJ, Tormo MJ, Barricarte Gurrea A, Lindkvist B, Manjer J, Johansson I, Ye W, Slimani N, Duell EJ, Jenab M, Michaud DS, Mouw T, Riboli E and Bueno-de-Mesquita HB: Ethanol intake and the risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 20: 785-794, 2009.
69. Turati F, Galeone C, Edefonti V, Ferraroni M, Lagiou P, La Vecchia C and Tavani A: A meta-analysis of coffee consumption and pancreatic cancer. Ann Oncol 23: 311-318, 2012.
70. Dong J, Zou J and Yu XF: Coffee drinking and pancreatic cancer risk: A meta-analysis of cohort studies. World J Gastroenterol 17: 1204-1210, 2011.
71. Yu X, Bao Z, Zou J and Dong J: Coffee consumption and risk of cancers: A meta-analysis of cohort studies. BMC Cancer 11: 96, 2011.
72. Bhoo-Pathy N, Uiterwaal CS, Dik VK, Jeurnink SM, Bech BH, Overvad K, Halkjaer J, Tjonneland A, Boutron-Ruault MC, Fagherazzi G, Racine A, Katzke VA, Li K, Boeing H, Floegel A, Androulidaki A, Bamia C, Trichopoulou A, Masala G, Panico S, Crosignani P, Tumino R, Vineis P, Peeters PH, Gavrilyuk O, Skeie G, Weiderpass E, Duell EJ, Arguelles M, Molina-Montes E, Navarro C, Ardanaz E, Dorronsoro M, Lindkvist B, Wallstrom P, Sund M, Ye W, Khaw KT, Wareham N, Key TJ, Travis RC, Duarte-Salles T, Freisling H, Licaj I, Gallo V, Michaud DS, Riboli E and Bueno-De-Mesquita HB: Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European prospective investigation into nutrition and cancer study. Clin Gastroenterol Hepatol 11: 1486-1492, 2013.
73. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K and van Leeuwen PA: Flavonoids: A review of probable mechanisms of action and potential applications. Am J Clin Nutr 74: 418-425, 2001.
74. Ramos S: Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways. Mol Nutr Food Res 52: 507-526, 2008.
75. Scalbert A, Manach C, Morand C, Remesy C and Jimenez L: Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45: 287-306, 2005.
76. Kuntz S, Wenzel U and Daniel H: Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity and apoptosis in human colon cancer cell lines. Eur J Nutr 38: 133-142, 1999.
77. Ramos S: Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 18: 427-442, 2007.
78. Araujo JR, Goncalves P and Martel F: Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr Res 31: 77-87, 2011.
79. Shankar S, Suthakar G and Srivastava RK: Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer. Front Biosci 12: 5039-5051, 2007.
80. Shankar S, Ganapathy S, Hingorani SR and Srivastava RK: EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci 13: 440-452, 2008.
81. Li Y, Zhang T, Jiang Y, Lee HF, Schwartz SJ and Sun D: (-)-Epigallocatechin-3-gallate inhibits HSP90 function by impairing HSP90 association with co-chaperones in pancreatic cancer cell line Mia Paca-2. Mol Pharm 6: 1152-1159, 2009.
82. Vu HA, Beppu Y, Chi HT, Sasaki K, Yamamoto H, Xinh PT, Tanii T, Hara Y, Watanabe T, Sato Y and Ohdomari I: Green tea epigallocatechin gallate exhibits anticancer effect in human pancreatic carcinoma cells via the inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor. J Biomed Biotechnol 2010: 290516.
83. Turati F, Galeone C, Talamini R, Franceschi S, Manzari M, Gallino G, Polesel J, La Vecchia C and Tavani A: Coffee, decaffeinated coffee, tea, and pancreatic cancer risk: A pooled-analysis of two Italian case-control studies. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation 20: 287-292, 2011.
84. Azeem K, Sevcikova J, Tomaskova H, Horakova D, Prochazka V, Martinek A, Shonova O, Janout V and Kollarova H: Pancreatic cancer and lifestyle factors. Klin Onkol 26: 257-262, 2013.
85. Nakamura K, Nagata C, Wada K, Tamai Y, Tsuji M, Takatsuka N and Shimizu H: Cigarette smoking and other lifestyle factors in relation to the risk of pancreatic cancer death: A prospective cohort study in Japan. Jpn J Clin Oncol 41: 225-231.
86. Lin Y, Kikuchi S, Tamakoshi A, Yagyu K, Obata Y, Kurosawa M, Inaba Y, Kawamura T, Motohashi Y and Ishibashi T: Green tea consumption and the risk of pancreatic cancer in Japanese adults. Pancreas 37: 25-30, 2008.
87. Wang J, Zhang W, Sun L, Yu H, Ni QX, Risch HA and Gao YT: Green tea drinking and risk of pancreatic cancer: A large-scale, population-based case-control study in urban Shanghai. Cancer Epidemiol 36: e354-358, 2012.
88. Mohammad RM, Wang S, Banerjee S, Wu X, Chen J and Sarkar FH: Nonpeptidic small-molecule inhibitor of BCL-2 and BCL-XL, (-)-Gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line. Pancreas 31: 317-324, 2005.
89. Wang Z, Ahmad A, Banerjee S, Azmi A, Kong D, Li Y and Sarkar FH: FoxM1 is a novel target of a natural agent in pancreatic cancer. Pharm Res 27: 1159-1168, 2010.
90. Xia J, Duan Q, Ahmad A, Bao B, Banerjee S, Shi Y, Ma J, Geng J, Chen Z, Rahman KM, Miele L, Sarkar FH and Wang Z: Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Curr Drug Targets 13: 1750-1756, 2012.
91. Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, Philip PA, Abbruzzese J and Sarkar FH: Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res 65: 9064-9072, 2005.
92. Banerjee S, Zhang Y, Wang Z, Che M, Chiao PJ, Abbruzzese JL and Sarkar FH: In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. Int J Cancer 120: 906-917, 2007.
93. Mohammad RM, Banerjee S, Li Y, Aboukameel A, Kucuk O and Sarkar FH: Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts. Cancer 106: 1260-1268, 2006.
94. El-Rayes BF, Philip PA, Sarkar FH, Shields AF, Ferris AM, Hess K, Kaseb AO, Javle MM, Varadhachary GR, Wolff RA and Abbruzzese JL: A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer. Invest New Drugs 29: 694-699, 2011.
95. Mohanty C, Acharya S, Mohanty AK, Dilnawaz F and Sahoo SK: Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: A novel controlled delivery vehicle for cancer therapy. Nanomedicine (Lond) 5: 433-449, 2010.
96. Sarkar FH, Banerjee S and Li Y: Pancreatic cancer: Pathogenesis, prevention and treatment. Toxicol Appl Pharmacol 224: 326-336, 2007.
97. Dhillon N, Aggarwal BB, Newman RA, Wolf RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V and Kurzrock R: Phase II trial of curcumin in patients with advanced pancreatic cancer. Clinical Cancer Research 14: 4491-4499, 2008.
98. Aggarwal BB, Kumar A and Bharti AC: Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Research 23: 363-398, 2003.
99. Epelbaum R, Rosenblatt E, Nasrallah S, Menashe N, Yardeni T, Faraggi D and Kuten A: Phase II study of gemcitabine (GEM) combined with radiation therapy (RT) in localized, unresectable pancreatic cancer. European Journal of Cancer 35: S148-S149, 1999.
100. Nadir A: Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer. Tel-Aviv Sourasky Medical Center 2005.
101. Kanai M, Yoshimura K, Asada M, Imaizumi A, Suzuki C, Matsumoto S, Nishimura T, Mori Y, Masui T, Kawaguchi Y, Yanagihara K, Yazumi S, Chiba T, Guha S and Aggarwal BB: A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol 68: 157-164, 2011.
102. Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP and Gescher AJ: Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol 60: 171-177, 2007.
103. Parasramka MA and Gupta SV: Synergistic effect of garcinol and curcumin on antiproliferative and apoptotic activity in pancreatic cancer cells. J Oncol 2012: 709739, 2012.
104. Duthie SJ: Folate and cancer: How DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis 34: 101-109, 2011.
105. Lamprecht SA and Lipkin M: Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer 3: 601-614, 2003.
106. Kurahara H, Takao S, Kuwahata T, Nagai T, Ding Q, Maeda K, Shinchi H, Mataki Y, Maemura K, Matsuyama T and Natsugoe S: Clinical Significance of Folate Receptor beta-expressing Tumor-associated Macrophages in Pancreatic Cancer. Ann Surg Oncol 2012.
107. Larsson SC, Hakansson N, Giovannucci E and Wolk A: Folate intake and pancreatic cancer incidence: A prospective study of Swedish women and men. J Natl Cancer Inst 98: 407-413, 2006.
108. Oaks BM, Dodd KW, Meinhold CL, Jiao L, Church TR and Stolzenberg-Solomon RZ: Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 91: 449-455, 2010.
109. Keszei AP, Verhage BA, Heinen MM, Goldbohm RA and van den Brandt PA: Dietary folate and folate vitamers and the risk of pancreatic cancer in the Netherlands cohort study. Cancer Epidemiol Biomarkers Prev 18: 1785-1791, 2009.
110. Skinner HG, Michaud DS, Giovannucci EL, Rimm EB, Stampfer MJ, Willett WC, Colditz GA and Fuchs CS: A prospective study of folate intake and the risk of pancreatic cancer in men and women. Am J Epidemiol 160: 248-258, 2004.
111. Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, Hartman TJ, Tangrea JA, Rautalahti M, Sehlub J, Virtamo J and Taylor PR: Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 91: 535-541, 1999.
112. Schernhammer E, Wolpin B, Rifai N, Cochrane B, Manson JA, Ma J, Giovannucci E, Thomson C, Stampfer MJ and Fuchs C: Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts. Cancer research 67: 5553-5560, 2007.
113. Chuang SC, Stolzenberg-Solomon R, Ueland PM, Vollset SE, Midttun O, Olsen A, Tjonneland A, Overvad K, Boutron-Ruault MC, Morois S, Clavel-Chapelon F, Teucher B, Kaaks R, Weikert C, Boeing H, Trichopoulou A, Benetou V, Naska A, Jenab M, Slimani N, Romieu I, Michaud DS, Palli D, Sieri S, Panico S, Sacerdote C, Tumino R, Skeie G, Duell EJ, Rodriguez L, Molina-Montes E, Huerta JM, Larranaga N, Gurrea AB, Johansen D, Manjer J, Ye W, Sund M, Peeters PH, Jeurnink S, Wareham N, Khaw KT, Crowe F, Riboli E, Buenode-Mesquita B and Vineis P: A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. European Journal of Cancer 47: 1808-1816, 2011.
114. Akhter J, Chen X, Bowrey P, Bolton EJ and Morris DL: Vitamin D-3 analog, EB1089, inhibits growth of subcutaneous xenografts of the human colon cancer cell line, LoVo, in a nude mouse model. Diseases of the colon and rectum 40: 317-321, 1997.
115. Schwartz GG, Eads D, Rao A, Cramer SD, Willingham MC, Chen TC, Jamieson DP, Wang L, Burnstein KL, Holick MF and Koumenis C: Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D-3. Carcinogenesis 25: 1015-1026, 2004.
116. Persons KS, Eddy VJ, Chadid S, Deoliveira R, Saha AK and Ray R: Anti-growth effect of 1,25-dihydroxyvitamin D3-3-bromoacetate alone or in combination with 5-amino-imidazole- 4-carboxamide-1-beta-4-ribofuranoside in pancreatic cancer cells. Anticancer Research 30: 1875-1880, 2010.
117. Schwartz GG, Eads D, Naczki C, Northrup S, Chen T and Koumenis C: 19-Nor-1 alpha,25-dihydroxyvitamin D-2 (paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo. Cancer biology & therapy 7: 430-436, 2008.
118. Schwartz GG and Blot WJ: Vitamin D status and cancer incidence and mortality: something new under the sun. J Natl Cancer Inst 98: 428-430, 2006.
119. Ferlay: GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC. CancerBase No. 10. Lyon, International Agency for Research. 2008.
120. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
121. Kinoshita S, Wagatsuma Y and Okada M: Geographical distribution for malignant neoplasm of the pancreas in relation to selected climatic factors in Japan. International journal of health geographics 6: 34, 2007.
122. Grant WB: An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94: 1867-1875, 2002.
123. Zablotska LB, Gong Z, Wang F, Holly EA and Bracci PM: Vitamin D, calcium, and retinol intake, and pancreatic cancer in a population-based case-control study in the San Francisco Bay area. Cancer causes & control: CCC 22: 91-100, 2011.
124. Skinner HG, Michaud DS, Giovannucci E, Willett WC, Colditz GA and Fuchs CS: Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev 15: 1688-1695, 2006.
125. Bao Y, Ng K, Wolpin BM, Michaud DS, Giovannucci E and Fuchs CS: Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. British journal of cancer 102: 1422-1427, 2010.
126. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ and Willett WC: Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98: 451-459, 2006.
127. Stolzenberg-Solomon RZ, Vieth R, Azad A, Pietinen P, Taylor PR, Virtamo J and Albanes D: A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res 66: 10213-10219, 2006.
128. Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Anderson KE, Hollis BW and Silverman DT: Serum vitamin D and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian screening trial. Cancer research 69: 1439-1447, 2009.
129. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ, McCullough ML, Purdue MP, Shu XO, Snyder K, Virtamo J, Wilkins LR, Yu K, Zeleniuch-Jacquotte A, Zheng W, Albanes D, Cai Q, Harvey C, Hayes R, Clipp S, Horst RL, Irish L, Koenig K, Le Marchand L and Kolonel LN: Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172: 81-93, 2010.
130. Liu SL, Zhao YP, Dai MH, You L, Wen Z and Xu JW: Vitamin D status and the risk of pancreatic cancer: a meta-analysis. Chin Med J (Engl) 126: 3356-3359, 2013.
131. Blanke CD, Beer TM, Todd K, Mori M, Stone M and Lopez C: Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer. Invest New Drugs 27: 374-378, 2009.
132. Foksinski M, Gackowski D, Rozalski R, Siomek A, Guz J, Szpila A, Dziaman T and Olinski R: Effects of basal level of antioxidants on oxidative DNA damage in humans. Eur J Nutr 46: 174-180, 2007.
133. Han X, Li J, Brasky TM, Xun P, Stevens J, White E, Gammon MD and He K: Antioxidant intake and pancreatic cancer risk: The Vitamins and Lifestyle (VITAL) Study. Cancer 119: 1314-1320, 2013.
134. Banim PJ, Luben R, McTaggart A, Welch A, Wareham N, Khaw K-T and Hart AR: Dietary antioxidants and the aetiology of pancreatic cancer: a cohort study using data from food diaries and biomarkers [published online ahead of print July 23, 2012]. Gut 2012.
135. Amaral AF, Porta M, Silverman DT, Milne RL, Kogevinas M, Rothman N, Cantor KP, Jackson BP, Pumarega JA, Lopez T, Carrato A, Guarner L, Real FX and Malats N: Pancreatic cancer risk and levels of trace elements. Gut 61: 1583-1588, 2012.
136. Burney PG, Comstock GW and Morris JS: Serologic precursors of cancer: serum micronutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutr 49: 895-900, 1989.
137. Heinen MM, Verhage BA, Goldbohm RA and van den Brandt PA: Intake of vegetables, fruits, carotenoids and vitamins C and E and pancreatic cancer risk in the Netherlands Cohort Study. Int J Cancer 130: 147-158, 2012.
138. Monti DA, Mitchell E, Bazzan AJ, Littman S, Zabrecky G, Yeo CJ, Pillai MV, Newberg AB, Deshmukh S and Levine M: Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One 7: e29794, 2012.
139. Schernhammer E, Wolpin B, Rifai N, Cochrane B, Manson JA, Ma J, Giovannucci E, Thomson C, Stampfer MJ and Fuchs C: Plasma folate, vitamin B6, vitamin B12 and homocysteine and pancreatic cancer risk in four large cohorts. Cancer Res 67: 5553-5560, 2007.
140. Gong Z, Holly EA and Bracci PM: Intake of folate, vitamins B6, B12 and methionine and risk of pancreatic cancer in a large population-based case-control study. Cancer Causes Control 20: 1317-1325, 2009.
141. Dong JY, Xun P, He K and Qin LQ: Magnesium intake and risk of type 2 diabetes: Meta-analysis of prospective cohort studies. Diabetes Care 34: 2116-2122, 2011.
142. Barbagallo M and Dominguez LJ: Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 458: 40-47, 2007.
143. Barbagallo M, Dominguez LJ and Resnick LM: Magnesium metabolism in hypertension and type 2 diabetes mellitus. Am J Ther 14: 375-385, 2007.
144. Lee DH, Folsom AR and Jacobs DR Jr.: Dietary iron intake and type 2 diabetes incidence in postmenopausal women: The Iowa Women's Health Study. Diabetologia 47: 185-194, 2004.
145. Fernandez-Real JM, Lopez-Bermejo A and Ricart W: Cross-talk between iron metabolism and diabetes. Diabetes 51: 2348-2354, 2002.
146. Kesavan Y, Giovannucci E, Fuchs CS and Michaud DS: A prospective study of magnesium and iron intake and pancreatic cancer in men. Am J Epidemiol 171: 233-241, 2010.
147. Molina-Montes E, Wark PA, Sanchez MJ, Norat T, Jakszyn P, Lujan-Barroso L, Michaud DS, Crowe F, Allen N, Khaw KT, Wareham N, Trichopoulou A, Adarakis G, Katarachia H, Skeie G, Henningsen M, Broderstad AR, Berrino F, Tumino R, Palli D, Mattiello A, Vineis P, Amiano P, Barricarte A, Huerta JM, Duell EJ, Quiros JR, Ye W, Sund M, Lindkvist B, Johansen D, Overvad K, Tjonneland A, Roswall N, Li K, Grote VA, Steffen A, Boeing H, Racine A, Boutron-Ruault MC, Carbonnel F, Peeters PH, Siersema PD, Fedirko V, Jenab M, Riboli E and Bueno-de-Mesquita B: Dietary intake of iron, heme-iron and magnesium and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort. Int J Cancer 131: E1134-1147, 2012.
148. Amaral AF, Porta M, Silverman DT, Milne RL, Kogevinas M, Rothman N, Cantor KP, Jackson BP, Pumarega JA, Lopez T, Carrato A, Guarner L, Real FX and Malats N: Pancreatic cancer risk and levels of trace elements. Gut 2011.
149. Nomura T, Tsuchiya Y, Nashimoto A, Yabusaki H, Takii Y, Nakagawa S, Sato N, Kanbayashi C and Tanaka O: Probiotics reduce infectious complications after pancreaticoduodenectomy. Hepatogastroenterology 54: 661-663, 2007.
150. Parkin DM: Tobacco-attributable cancer burden in the UK in 2010. British journal of cancer 105(Suppl 2): S6-S13, 2011.
151. Qiu D, Kurosawa M, Lin Y, Inaba Y, Matsuba T, Kikuchi S, Yagyu K, Motohashi Y and Tamakoshi A: Overview of the epidemiology of pancreatic cancer focusing on the JACC Study. J Epidemiol 15(Suppl 2): S157-167, 2005.
152. Wittel UA, Pandey KK, Andrianifahanana M, Johansson SL, Cullen DM, Akhter MP, Brand RE, Prokopczyk B and Batra SK: Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am J Gastroenterol 101: 148-159, 2006.
153. Rebours V, Boutron-Ruault MC, Schnee M, Ferec C, Maire F, Hammel P, Ruszniewski P and Levy P: Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: A national exhaustive series. The American journal of gastroenterology 103: 111-119, 2008.
154. Raimondi S, Maisonneuve P, Lohr JM and Lowenfels AB: Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors. Cancer Epidemiol Biomark Prev 16: 1894-1897, 2007.
155. Vrieling A, Bueno-de-Mesquita HB, Boshuizen HC, Michaud DS, Severinsen MT, Overvad K, Olsen A, Tjonneland A, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Rohrmann S, Boeing H, Nothlings U, Trichopoulou A, Moutsiou E, Dilis V, Palli D, Krogh V, Panico S, Tumino R, Vineis P, van Gils CH, Peeters PH, Lund E, Gram IT, Rodriguez L, Agudo A, Larranaga N, Sanchez MJ, Navarro C, Barricarte A, Manjer J, Lindkvist B, Sund M, Ye W, Bingham S, Khaw KT, Roddam A, Key T, Boffetta P, Duell EJ, Jenab M, Gallo V and Riboli E: Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. International journal of cancer Journal international du cancer 126: 2394-2403, 2010.
156. Kim HG and Han J: Obesity and pancreatic diseases. Korean J Gastroenterol 59: 35-39, 2012.
157. Pelucchi C, Zucchetto A, Tavani A, Dal Maso L, Serraino D and La Vecchia C: Physical activity and pancreatic cancer risk. Int J Cancer 128: 2243-2245, 2011.
158. Aune D, Greenwood DC, Chan DS, Vieira R, Vieira AR, Navarro Rosenblatt DA, Cade JE, Burley VJ and Norat T: Body mass index, abdominal fatness and pancreatic cancer risk: A systematic review and non-linear dose-response meta-analysis of prospective studies. Annals of oncology : official journal of the European Society for Medical Oncology/ESMO 23: 843-852, 2012.
159. Levi Z, Kark JD, Afek A, Derazne E, Tzur D, Furman M, Gordon B, Barchana M, Liphshitz I, Niv Y and Shamiss A: Measured body mass index in adolescence and the incidence of pancreatic cancer in a cohort of 720,000 Jewish men. Cancer Causes Control 23: 371-378, 2012.
160. Bourhis J, Lacaine F, Augusti M and Huguier M: Protective effect of oestrogen in pancreatic cancer. Lancet 2: 977, 1987.
161. Duell EJ, Travier N, Lujan-Barroso L, Dossus L, Boutron-Ruault MC, Clavel-Chapelon F, Tumino R, Masala G, Krogh V, Panico S, Ricceri F, Redondo ML, Dorronsoro M, Molina-Montes E, Huerta JM, Barricarte A, Khaw KT, Wareham NJ, Allen NE, Travis R, Siersema PD, Peeters PH, Trichopoulou A, Fragogeorgi E, Oikonomou E, Boeing H, Schuetze M, Canzian F, Lukanova A, Tjonneland A, Roswall N, Overvad K, Weiderpass E, Gram IT, Lund E, Lindkvist B, Johansen D, Ye W, Sund M, Fedirko V, Jenab M, Michaud DS, Riboli E and Bueno-de-Mesquita HB: Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer 132: 2164-2175, 2013.